Skip to content

Financial Times: European cannabis companies start IPO planning as US considers looser rules

Jul. 16, 2024 by SOMAÍ Pharmaceuticals

A number of European cannabis start-ups are planning to go public in New York to take advantage of a US proposal to reclassify marijuana as a less dangerous drug and decriminalisation in Germany, despite depressed share prices among bigger groups in the sector.